OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance
Abbas Navabi, Bahman Akbari, Mohammad Abdalsamadi, et al.
Life Sciences (2022) Vol. 296, pp. 120437-120437
Closed Access | Times Cited: 13
Abbas Navabi, Bahman Akbari, Mohammad Abdalsamadi, et al.
Life Sciences (2022) Vol. 296, pp. 120437-120437
Closed Access | Times Cited: 13
Showing 13 citing articles:
mir-188‐5p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2
Osman Akıdan, Nina Petrović, Sema Mısır
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Osman Akıdan, Nina Petrović, Sema Mısır
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Signaling pathways governing the behaviors of leukemia stem cells
Shirin Azizidoost, Ava Nasrolahi, Mohadeseh Sheykhi-Sabzehpoush, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 830-846
Open Access | Times Cited: 9
Shirin Azizidoost, Ava Nasrolahi, Mohadeseh Sheykhi-Sabzehpoush, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 830-846
Open Access | Times Cited: 9
The Emerging Role of Extracellular Vesicle Derived From Neurons/Neurogliocytes in Central Nervous System Diseases: Novel Insights Into Ischemic Stroke
Fan Li, Xiaokui Kang, Wenqiang Xin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Fan Li, Xiaokui Kang, Wenqiang Xin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1
Xiuyan Zhang, Wenjuan Ma, Wen Xue, et al.
Cellular and Molecular Life Sciences (2023) Vol. 81, Iss. 1
Open Access | Times Cited: 6
Xiuyan Zhang, Wenjuan Ma, Wen Xue, et al.
Cellular and Molecular Life Sciences (2023) Vol. 81, Iss. 1
Open Access | Times Cited: 6
miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells
Yutthana Rittavee, Jérôme Artus, Christophe Desterke, et al.
Experimental Hematology (2022) Vol. 118, pp. 40-52
Open Access | Times Cited: 8
Yutthana Rittavee, Jérôme Artus, Christophe Desterke, et al.
Experimental Hematology (2022) Vol. 118, pp. 40-52
Open Access | Times Cited: 8
Novel targeted therapies in chronic myeloid leukemia
Muhammad Sameer Ashaq, Qian Zhou, Zhuoran Li, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100052-100052
Open Access | Times Cited: 1
Muhammad Sameer Ashaq, Qian Zhou, Zhuoran Li, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100052-100052
Open Access | Times Cited: 1
Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women
Alex Habel, Farah Nassar, M. Itani, et al.
African Health Sciences (2023) Vol. 23, Iss. 2, pp. 256-64
Open Access | Times Cited: 2
Alex Habel, Farah Nassar, M. Itani, et al.
African Health Sciences (2023) Vol. 23, Iss. 2, pp. 256-64
Open Access | Times Cited: 2
Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels
Manvi Bansal, Sana Ansari, Malkhey Verma
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access
Manvi Bansal, Sana Ansari, Malkhey Verma
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
Alvea Tasneem, Archana Sharma, Mansoor Ali Syed, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Alvea Tasneem, Archana Sharma, Mansoor Ali Syed, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
Sara Anvari, Mohsen Nikbakht, Mohammad Vaezi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Sara Anvari, Mohsen Nikbakht, Mohammad Vaezi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia
Xiao Wang, Simin Simin, Yunxiao Sun, et al.
Oncology Reports (2023) Vol. 50, Iss. 2
Open Access | Times Cited: 1
Xiao Wang, Simin Simin, Yunxiao Sun, et al.
Oncology Reports (2023) Vol. 50, Iss. 2
Open Access | Times Cited: 1
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways
Michał Janowski, Zofia Ulańczyk, Karolina Łuczkowska, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1123-1141
Open Access | Times Cited: 2
Michał Janowski, Zofia Ulańczyk, Karolina Łuczkowska, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1123-1141
Open Access | Times Cited: 2
miR-495-3p Sensitizes BCR::ABL1 Expressing Leukemic cells to Tyrosine Kinase Inhibitors by Targeting Multidrug Resistance 1 Gene including in T315I Mutated cells
Yutthana Rittavee, Jérôme Artus, Christophe Desterke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Yutthana Rittavee, Jérôme Artus, Christophe Desterke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
